
Marissa Fahlberg
Articles
-
Nov 1, 2024 |
jitc.bmj.com | Trevor Brown |Marissa Fahlberg |Sarah Forward |Emane Rose Assita
AbstractBackground Cell therapy has been successful for treating some hematological malignancies, largely through autologous chimeric antigen receptor (CAR) T-cell therapies. However, the complexity of CAR T-cell therapies makes them costly and time-consuming to develop.
-
Jan 30, 2023 |
nature.com | Henry Sutton |Chris Cottrell |Ivy Phung |Gabriel Ozorowski |Jonathan Torres |Wen-Hsin Lee | +10 more
Author notesThese authors contributed equally: Jeong Hyun Lee, Henry J. SuttonAuthors and AffiliationsCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USAJeong Hyun Lee, Henry J. Sutton, Ivy Phung, Catherine Nakao, Kimberly M. Cirelli & Shane CrottyConsortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USAJeong Hyun Lee, Henry J. Sutton, Christopher A.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →